Remote Bioreactor Control & Lab Automation Capabilities Are Critical to Lab Performance and Safety - Video
Life science companies across the globe are confronting new and unprecedented challenges caused by the coronavirus/COVID-19 pandemic.
Whether its medical device companies rushing to produce N95 masks or ventilators, public health academic institutions tracking COVID-19's spread, or biotechs and pharma companies battling to keep their drug products moving forward in a time of extreme uncertainty, the coronavirus has changed everything.
That includes the number of drug development staff a life science organization can have in the lab at once. It also means these lab techs and research scientists are often the only staff physically onsite, as many of the country's largest life science companies have issued orders for non-lab staff to work remotely for the foreseeable future...
https://bit.ly/3c1RMkf
Whether its medical device companies rushing to produce N95 masks or ventilators, public health academic institutions tracking COVID-19's spread, or biotechs and pharma companies battling to keep their drug products moving forward in a time of extreme uncertainty, the coronavirus has changed everything.
That includes the number of drug development staff a life science organization can have in the lab at once. It also means these lab techs and research scientists are often the only staff physically onsite, as many of the country's largest life science companies have issued orders for non-lab staff to work remotely for the foreseeable future...
https://bit.ly/3c1RMkf
-
Most popular related searches
Customer comments
No comments were found for Remote Bioreactor Control & Lab Automation Capabilities Are Critical to Lab Performance and Safety - Video. Be the first to comment!